Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism PIKFYVE inhibitors(phosphoinositide kinase, FYVE-type zinc finger containing inhibitors), c-Met inhibitors(Hepatocyte growth factor receptor inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Corneal Dystrophy, Fleck | Discovery | - | 13 Apr 2023 | |
| Endocrinology and Metabolic Disease | Discovery | - | 13 Apr 2023 | |
| Erythrokeratodermia Variabilis | Discovery | - | 13 Apr 2023 | |
| Immune System Diseases | Discovery | - | 13 Apr 2023 | |
| Infectious Diseases | Discovery | - | 13 Apr 2023 | |
| Neoplasms | Discovery | - | 13 Apr 2023 | |
| Nervous System Diseases | Discovery | - | 13 Apr 2023 | |
| Other Diseases | Discovery | - | 13 Apr 2023 |





